CA-THALES
6.10.2021 07:02:05 CEST | Business Wire | Press release
Thales and Google Cloud today announced a strategic agreement to co-develop a sovereign hyperscale cloud offering for France. Operated by a joint company with Thales as the majority shareholder, it will meet the criteria of the French ‘Trusted Cloud.’ With this new offering, French companies and public sector organizations will benefit from all the power, security, flexibility, agility and sovereignty offered by the respective technologies of the two organizations.
By addressing the highest legal and technical requirements for ‘Trusted Cloud’, the Thales and Google Cloud offering will enable private and public sector organisations who need to meet the criteria - defined by France’s Information Systems Security Agency (ANSSI)2 - to benefit from cloud computing services, in accordance with the country’s sovereign cloud strategy.
The joint offer of Thales and Google Cloud is based on the most advanced technologies and services of each partner. Google Cloud’s services, which will be enhanced and complemented with new innovations regularly, will bring elasticity, agility and technological openness, enabling companies to innovate transparently and autonomously, without vendor lock-in.
Thales, a leader in cybersecurity for more than 40 years, will bring the necessary guarantees of France’s sovereignty requirements by ensuring the management of encryption keys, access, identities, and cyber threat monitoring with its Cybersecurity Operations Center. Thales thus provides the levels of trust and of security required from French customers so that they can migrate their most sensitive applications to the cloud while maintaining control.
French companies and public sector institutions will be able to benefit from a set of hyperscale cloud services that are:
- operated by a dedicated, newly formed company under French law, held in majority by Thales;
- hosted in France, within infrastructure that is separate from Google Cloud, with a separate network and servers controlled and operated by the new company;
- supported locally by the new company, ensuring customer service is handled in France;
- locally secured with identity management, data encryption, administration and supervision being provided by the new company;
- regularly enhanced via rolling software updates that are evaluated and validated within a security sandbox managed by Thales; and
- managed on a sustainably developed infrastructure.
"To adapt to the diversity of our customers’ cloud needs, Thales offers a wide range of options with partners in its ecosystem. Thanks to this unique collaboration with Google Cloud, we will be able to help power the digital transformation for organizations of all sizes and industries that want to keep control and sovereignty over their data and that of their customers. Together, we will address the criteria defined by the government for a trusted cloud, as well as environmental goals with a sustainable approach for the infrastructure we will build,” said Marc Darmon, Executive Vice President, Secure Communications and Information Systems at Thales.
“Thales and Google Cloud have a joint vision to deliver the most innovative and trusted solutions to companies and public sector organizations in France. Our unique approach to addressing the concerns of French citizens and government bodies, including the development of a new company, ensures organizations can benefit from the innovation and agility of the cloud, without compromising on the security, privacy and sovereignty required by the French government,” said Thomas Kurian, CEO at Google Cloud.
“The government's national cloud strategy clearly specifies the state's willingness to use and promote high-performance and trusted cloud offerings. The challenge is to have the widest possible range of solutions compliant with the SecNumCloud repository which details the technical, operational and legal security rules capable of effectively protecting data and processes hosted in a cloud service. ANSSI therefore enthusiastically welcomes this ambitious project that meets these criteria," said Guillaume Poupard, Director General of the National Information Systems Security Agency (ANSSI.)
About Google Cloud
Google Cloud accelerates organizations' ability to digitally transform their business with the best infrastructure, platform, industry solutions and expertise. We deliver enterprise-grade solutions that leverage Google's cutting-edge technology – all on the cleanest cloud in the industry. Customers in more than 200 countries and territories turn to Google Cloud as their trusted partner to enable growth and solve their most critical business problems.
About Thales
Thales (Euronext Paris: HO) is a global leader in advanced technologies, investing in digital and “deep tech” innovations – connectivity, big data, artificial intelligence, cybersecurity and quantum computing – to build a confident future crucial for the development of our societies. The Group provides its customers – businesses, organisations and governments – in the defense, aeronautics, space, transport, and digital identity and security domains with solutions, services and products that help them fulfil their critical role, consideration for the individual being the driving force behind all decisions.
Thales has 81,000 employees in 68 countries. In 2020 the Group generated sales of €17 billion.
1
“Hyperscale” refers to cloud computing based on an optimized computing architecture in terms of storage, power, energy consumption and scalability.
2
The Trusted Cloud label will offer a double level of security – both legal and technical – and will allow French companies and administrations to benefit from the best cloud services. Some of the world’s most efficient cloud services are published by non-European companies: these services will also be eligible for the label under certain conditions, notably concerning the entity operating these services and the location of the data. (source: https://www.numerique.gouv.fr/uploads/Strategie-nationale-pour-le-cloud.pdf
)
View source version on businesswire.com: https://www.businesswire.com/news/home/20211005005894/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
IMPACT Therapeutics and Pharmanovia Announce Positive CHMP Opinion for Senaparib, as a Potential First-Line Maintenance Treatment of Advanced High-Grade Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer18.9.2026 12:38:00 CEST | Press release
For business and medical media only This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918325771/en/ Stephan Eder, CEO, Pharmanovia IMPACT Therapeutics (07630.HK), a commercial-stage biotechnology company focused on the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality mechanisms, together with global specialty pharmaceutical company Pharmanovia, today jointly announce that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a Marketing Authorisation (MA) for the medicinal product Sepalna® (senaparib) intended for the maintenance treatment of advance epithelial ovarian, fallopian tube and primary peritoneal cancer. Following the CHMP’s recommendation for approval, senaparib will be submitted to the European Commission (EC) for final decision. Once approved by the EC, senaparib will
Estithmar Holding Announces Completion of 48.68% Stake Transfer in Shahba Bank to Masaref Holding, a Subsidiary of Estithmar Capital18.9.2026 11:48:00 CEST | Press release
Estithmar Holding Q.P.S.C. announced the completion of the transfer of a 48.68% stake in Shahba Bank to Masaref Holding LLC, subsidiary of Estithmar Capital, Estithmar Holding’s financial services and investments arm. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918807909/en/ Estithmar Holding Announces Completion of 48.68% Stake Transfer in Shahba Bank to Masaref Holding, a Subsidiary of Estithmar Capital (Photo: AETOSWire) As a shareholder, Masaref Holding intends to support the assessment of proposals aimed at strengthening Shahba Bank’s financial, operational and technological capabilities, including potential capital enhancement, branch network expansion, and the development of products and services for individuals, businesses and SMEs. The proposals may include modernizing banking and operational systems, develop digital services, and strengthen governance, compliance, risk management and cybersecurity to enhance
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
